The Mission of HemoCleanse, Inc. is:

To be the world leader in the development and commercialization of innovative sorbent-based extracorporeal therapies that are clinically effective and efficient -- saving lives, reducing healthcare costs, and improving the quality of care and life for patients suffering from chronic diseases.

Commentary

We at HemoCleanse, Inc. are interested in developing technologies that can have a dramatic impact on how long people live. Our success in the treatment of kidney failure (Renal Solutions, Inc.) and liver failure (HemoCleanse Technologies, LLC) are dramatic examples.

But equally significant to a longer life on earth, we are passionate about technologies that can improve the quality of life for patients of all ages.

We believe that a long life is so much better when it is a good life, full of the kind of activities that were previously unattainable by those who were facing illness and disease.

This is a passion of which we will never lose sight, as we seek to discover and develop technologies to remediate, alleviate, manage and prevent significant chronic diseases and illness.

It is the clarion call that led to the development of a more compact, more mobile, more user friendly home dialysis system (Renal Solutions, Inc.) that will treat kidney failure patients away from the clinical setting, and closer to their family support system.

It is also the clarion call that has let us to develop a second generation sorbent-based dialysis unit that might someday lead to out-patient treatment of chronic diseases such as hepatitis, rheumatoid arthritis, and lupus. Please join us in our enthusiasm for dramatic emerging technologies that will impact our world, as you explore our website, and get to know HemoCleanse, Inc. a little better.

Return to About Us